Ignite Creation Date:
2025-12-25 @ 4:36 AM
Ignite Modification Date:
2026-03-13 @ 1:20 AM
Study NCT ID:
NCT02993718
Status:
COMPLETED
Last Update Posted:
2017-09-14
First Post:
2016-12-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sedation by Dexmedetomidine and Propofol
Sponsor:
Seoul National University Bundang Hospital
Organization:
Study Overview
Official Title:
Comparison of the Upper Airway Patency by Dexmedetomidine and Propofol Used for Sedation
Status:
COMPLETED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Under the hypothesis that dexmedetomidine sedation would result in less upper airway obstruction, we evaluated the occurrence of upper airway collapse or the requirement of airway intervention in patients with obstructive sleep apnea during dexmedetomidine or propofol sedation.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: